Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.460
+0.070 (5.04%)
At close: Jan 17, 2025, 4:00 PM
1.480
+0.020 (1.37%)
After-hours: Jan 17, 2025, 7:51 PM EST
Atai Life Sciences Employees
Atai Life Sciences had 83 employees as of December 31, 2023. The number of employees decreased by 50 or -37.59% compared to the previous year.
Employees
83
Change (1Y)
-50
Growth (1Y)
-37.59%
Revenue / Employee
$3,988
Profits / Employee
-$1,549,434
Market Cap
244.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 83 | -50 | -37.59% |
| Dec 31, 2022 | 133 | 46 | 52.87% |
| Dec 31, 2021 | 87 | 52 | 148.57% |
| Dec 31, 2020 | 35 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ATAI News
- 10 days ago - atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health - GlobeNewsWire
- 3 months ago - IntelGenx is Granted Court Approval of the Sale Proposal from atai Life Sciences AG - GlobeNewsWire
- 4 months ago - atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Psychedelic Stock Deep Dive: Atai Life Sciences - Seeking Alpha
- 5 months ago - atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 5 months ago - Psychedelic drug contender stocks drop after FDA rejects MDMA treatment - Market Watch
- 5 months ago - atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference - GlobeNewsWire
- 7 months ago - atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference - GlobeNewsWire